Home Newsfeeds Baird Maintains Outperform on VF, Raises Price Target to $42

Baird Maintains Outperform on VF, Raises Price Target to $42

Baird analyst Jonathan Komp maintains VF (NYSE:VFC) with a Outperform and raises the price target from $40 to $42.

byBenzinga Newsdesk

December 1, 2022

1 minute read

Baird analyst Jonathan Komp maintains VF (NYSE:VFC) with a Outperform and raises the price target from $40 to $42.

Medical Device Provider Silk Road Pioneers Innovative Stroke Prevention Method: Analyst

By Vandana Singh

September 6, 2:52 PM

Oppenheimer has initiated coverage on Silk Road Medical Inc (NASDAQ: SILK) with an Outperform rating and

SILK

Barclays Initiates Coverage On InMode with Overweight Rating, Announces Price Target of $44

By Benzinga Newsdesk

December 21, 8:00 AM

Barclays analyst Matt Miksic initiates coverage on InMode (NASDAQ:INMD) with a Overweight rating and announces Price Target of $44.

INMD

News

Cummins, Inc. Makes Minority Investment In Exergy Energy; Terms Not Disclosed

By Benzinga Newsdesk

November 11, 10:02 AM

The Cummins – Exergy Energy partnership allows for the installation of Cummins power system solutions such as generator sets, energy storage systems, and switching equipment at the customer location to power the

CMI

‘The Jewel In The Crown’: How Data Is Shaping Cannabis Retail, ‘Customers Are Key’, Says Item 9 Labs CEO

By Joana Scopel

August 11, 1:57 PM

"Data point is definitely the jewel in your crown to be able to understand the consumer," said Sarah Kabakoff, VP of business development at Dutchie, at the recent Benzinga Cannabis Capital Conference in Miami.

GTBIF

Baird Maintains Outperform on VF, Raises Price Target to $42

Related Posts

Medical Device Provider Silk Road Pioneers Innovative Stroke Prevention Method: Analyst

Barclays Initiates Coverage On InMode with Overweight Rating, Announces Price Target of $44

Cummins, Inc. Makes Minority Investment In Exergy Energy; Terms Not Disclosed

‘The Jewel In The Crown’: How Data Is Shaping Cannabis Retail, ‘Customers Are Key’, Says Item 9 Labs CEO